The NHS is to provide GPs an extra £10 for every care home resident they are able to vaccinate against COVID by the end of January in an accelerated drive to protect the most vulnerable.
The Government has accepted the recommendation from the Medicines and Healthcare products Regulatory Agency (MHRA) to authorise Oxford University/AstraZeneca’s COVID-19 vaccine for use.
NICE, the Royal College of General Practitioners (RCGP) and the Scottish Intercollegiate Guidelines Network (SIGN) have published a guideline on the management of the long-term effects of COVID-19 (also known as Long COVID).
The Government has published figures which show the number of people who have received the vaccine between 8 December and 20 December in the UK is 616,933.
Pregnant women are among those most in need of safe, effective therapies against COVID-19, but they are routinely excluded from the majority of clinical treatment trials, according to authors of a paper, published in The Lancet Global Health journal.
A new poll by the Royal Society for Public Health has revealed that three in four (76%) of the UK public would take a COVID-19 vaccine if advised to do so by their GP or health professional, with just 8% stating they would be very unlikely to do so.
More than 137,000 people in the UK have received the first dose of the Pfizer/BioNTech COVID-19 vaccine in the first week of the largest vaccination programme in British history.
Researchers at the University of Maryland, Baltimore County (UMBC) have developed a method of generating high-quality chest X-ray images that can be used to diagnose COVID-19 more accurately than current methods.
A team of thoracic consultants from Guy’s and St Thomas’ NHS Foundation Trust has uncovered important findings on the use of chest drains during the COVID pandemic.
Interim results of the Oxford COVID-19 vaccine trials find that the vaccine protects against symptomatic disease in 70% of cases
Interim results from the seventh report of one of the country’s largest studies into COVID-19 infections in England have been published by Imperial College London and Ipsos MORI.
The lives of patients hospitalised with COVID-19 are being saved by doctors who are using an existing medical treatment at an earlier stage.
Sheffield Teaching Hospitals NHS Foundation Trust is one of 17 sites across the country, and the only one in the Yorkshire and Humber, to have been selected to trial the latest Covid-19 candidate vaccine.
The Vivaldi 2 study will more than triple in size to provide a detailed picture of coronavirus infection in care homes in England.
Beckman Coulter has announced the launch of its Access SARS-CoV-2 Immunoglobulin M (IgM) assay in countries accepting the CE Mark.
Responding to the Prime Minister’s statement on coronavirus, NHS Medical Director, Professor Stephen Powis, said: “Daily hospital COVID admissions are now higher than on 23 March when the Prime Minister announced the first national lockdown.
Imperial’s COVID-19 vaccine lead, Professor Robin Shattock, has told MPs that there is uncertainty around the immunity that a vaccine will offer; boosting strategies may be required and we are likely to be living with the virus for years to come.